Nautilus Biotechnology

Nautilus Biotechnology is a company listed under the stock ticker NAUT (US).

View the org chart displaying its 19 main executives

Martin Huber has joined the company as Vice President of Biochemistry and Flow Cell Development (posted on November 1 2023).

Create your alert
to follow the executive moves at Nautilus Biotechnology.

Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
Histogen has filed for bankruptcy protection (posted on April 19 2024).

Contact by email its executives including Matthew Posard Premium

The best decision-maker directory

Discover the organization charts of your favorite companies.

Spot the influential executives using our search tools.

Receive notifications when executive positions change.

Fuel your company's success with our real-time data.

Individual Access

Executive Data Sets

Executives

Companies

The Official Board